Dexcom Inc. buy Wells Fargo & Company
Start price
10.03.25
/
50%
€67.35
Target price
10.03.26
-
Performance (%)
-12.43%
Price
13.02.26
€58.98
Summary
This prediction is currently active. The prediction for Dexcom Inc. disappoints with a performance of -12.43%. This prediction currently runs until 10.03.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dexcom Inc. | -0.372% | -0.372% |
| iShares Core DAX® | 0.463% | -1.999% |
| iShares Nasdaq 100 | -1.792% | -5.743% |
| iShares Nikkei 225® | 5.124% | 9.091% |
| iShares S&P 500 | -1.760% | -3.669% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Dexcom Inc. diskutieren
DexCom, Inc. (NASDAQ: DXCM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.
Ratings data for DXCM provided by MarketBeat